September 21st, 2011 by GarySchwitzer in News, Opinion
No Comments »
MedPage Today reports:
Mehmet Oz, MD, the Columbia University thoracic surgeon who gained fame first in books and more recently with his syndicated television show, has run afoul of the Food and Drug Administration with his report about levels of arsenic in popular brands of apple juice.
The FDA called the report “irresponsible and misleading” and another TV doc, ABC’s Richard Besser, MD, accused Oz of fear-mongering.
Fox News’ Dr. Manny Alvarez rushes to Oz’s defense, though:
“I’m very proud of Dr. Oz for his report today on potentially dangerous levels of arsenic found in certain brands of apple juice, which may classify some of them as unsuitable for consumption. He’s sounding the alarm for an issue that I believe needs to be brought to attention.
…
Don’t get me wrong, I don’t want to Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
September 20th, 2011 by RamonaBatesMD in Research
No Comments »
Somewhere along the line I learned to encourage women with a family history of breast cancer to begin getting mammograms at an age 10 years prior to when their mother was diagnosed and to encourage their daughters to begin getting mammograms at an age 10 years prior to when they themselves were ever diagnosed.
I learned this prior to the discovery of BRCA genes. It was a trend that had been noted among women with strong family histories. The new study (see full reference below) in the journal Cancer verifies that genetic breast cancers show up earlier in the next generation – on average by 8 years.
The study from MD Anderson looked at 2 generations of families with the BRCA gene to assess the age at diagnosis. Using the pool of 132 BRCA-positive women with breast cancer who participated in the high-risk protocol at The University of Texas MD Anderson Cancer Center (Gen 2), 106 women could be paired with a family member in the previous generation (Gen 1) who was diagnosed with a BRCA-related cancer (either breast cancer or ovarian cancer).
The median age of cancer diagnosis was Read more »
*This blog post was originally published at Suture for a Living*
September 14th, 2011 by Peggy Polaneczky, M.D. in Research
No Comments »
The idea that heart disease mortality rises dramatically at menopause has been one of the truisms of medicine that spawned a generation of hormone use by women and led to the rise and subsequent fall of Prempro in the Women’s Health Initiative, the end-all-be-all study that failed to prove the truism. The truism is still so strongly believed that research to prove it right continues, using different hormone formulations and different cohorts of women, in the hopes that the hormonal fountain of youth was just misbranded and given to the wrong aged cohort.
Now comes a landmark study that suggests that what we’ve thought all along about heart disease and menopause may actually be wrong.
Dhananjay Vaidya and colleagues at Johns Hopkins and the University of Alabama have re-analyzed mortality data on men and women in the UK and US and concluded that, contrary to popular belief, heart disease rates and mortality do not increase dramatically with menopause, but rather rise more gradually as a function of age in both men and women.
“Our data show there is Read more »
*This blog post was originally published at The Blog That Ate Manhattan*
September 4th, 2011 by Medgadget in News, Research
No Comments »
Though mastectomies are often a necessary and even welcome intervention to save the lives of women suffering from breast cancer, they also may contribute to the overall physical and emotional trauma facing the patients. In order to alleviate some of these problems, surgeons have developed breast reconstruction procedures that usually entail restoring the mound by implanting a silicone sac filled with salt solution (saline) or gel under the skin and pectoral muscles. The traditional process to prepare for implantation of the sac may be long and sometimes painful because it involves weekly bolus saline injections (sometimes up to 22 weeks) in order to create a pocket of sufficient size.
A potential alternative solution is being developed by AirXpanders, a med tech start-up in Palo Alto that focuses on tissue expansion for breast reconstruction following cancer. Their system, known as AeroForm, just recently Read more »
*This blog post was originally published at Medgadget*
August 13th, 2011 by RyanDuBosar in Research
No Comments »
British researchers identified a faulty gene associated with a one-in-11 chance of developing ovarian cancer, and they think drugs for breast cancer might also work in these women.
Researchers from England’s Institute of Cancer Research reported that they compared DNA from women from 911 families with ovarian and breast cancer and to a control group of 1,060 people from the general population.
They found eight gene faults in theRAD51Dgene in women with cancer, compared with one in the control group. TheRAD51Dgene repairs damaged DNA, and when it’s faulty, cells are more likely to turn cancerous.
Results appear Read more »
*This blog post was originally published at ACP Internist*
